Efficacy and safety of 1% clascoterone cream through 12 weeks in patients ≥12 years of age with facial acne vulgaris

被引：0
|
作者：
Cartwright, Martina [1 ]
Moro, Luigi [2 ]
Fragasso, Enrico [2 ]
机构：
[1] Cassiopea Inc, San Diego, CA USA
[2] Cassiopea SpA, Lainate, Italy
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34781
引用
收藏
页码：AB49 / AB49
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Once-Daily Luliconazole 1% Cream in Patients ≥12 Years of Age With Interdigital Tinea Pedis: A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Study
    Jarratt, Michael
    Jones, Terry
    Adelglass, Jeffrey
    Bucko, Alicia
    Pollak, Richard
    Roman-Miranda, Amaury
    Olin, Jason T.
    Swinyer, Leonard
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (07) : 838 - 846
  • [32] Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy
    Renfroe, J. Ben
    Mintz, Mark
    Davis, Ronald
    Ferreira, Jose
    Dispoto, Sharon
    Ferry, Jim
    Umetsu, Yuko
    Rege, Bhaskar
    Majid, Oneeb
    Hussein, Ziad
    Laurenza, Antonio
    JOURNAL OF CHILD NEUROLOGY, 2019, 34 (05) : 284 - 294
  • [33] Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeding episodes in paediatric patients with severe haemophilia A and below 12 years of age
    Kulkarni, R.
    Karim, F. Abdul
    Glamocanin, S.
    Janic, D.
    Vdovin, V.
    Ozelo, M.
    Rageliene, L.
    Carboni, E.
    Laguna, P.
    Dobaczewski, G.
    Santagostino, E.
    HAEMOPHILIA, 2012, 18 (05) : 829 - 829
  • [34] Adapalene 0.1%/Benzoyl Peroxide 2.5% GelA Review of its Use in the Treatment of Acne Vulgaris in Patients Aged ≥12 Years
    Gillian M. Keating
    American Journal of Clinical Dermatology, 2011, 12 : 407 - 420
  • [35] Efficacy and safety of Spironolactone in treating patients with acne vulgaris: a systematic review and meta-analysis of 1,086 patients
    Farrag, Mohamed
    Elnaga, Ahmed A. Abo
    Alsaied, Mohamed A.
    Serag, Ibrahim
    Elkholy, Mohamed Karam Allah
    Ibrahim, Omar H.
    Elettreby, Abdelrahman M.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [36] Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review
    Sato, Junya
    Kodaira, Makoto
    Harada, Hiroyuki
    Iguchi, Haruo
    Yoshida, Taichi
    Shibata, Hiroyuki
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (07) : 1160 - 1172
  • [37] The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial
    Azizzadeh, Maryam
    Pahlevan, Daryoush
    Bagheri, Bahador
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (05) : 926 - 931
  • [38] Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study
    Karoglan, Ante
    Paetzold, Bernhard
    Pereira De Lima, Joao
    Bruggemann, Holger
    Tuting, Thomas
    Schanze, Denny
    Guell, Marc
    Gollnick, Harald
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (13) : 1253 - 1257
  • [39] Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study
    Mazzetti, Alessandro
    Moro, Luigi
    Gerloni, Mara
    Cartwright, Martina
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (06) : 563 - 568
  • [40] Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema less than 12 years of age
    Schranz, J.
    Ledford, D.
    Gower, R.
    Soteres, D.
    Jacobson, K.
    Li, H.
    Lumry, W.
    Fitts, D.
    Kreuz, W.
    ALLERGY, 2014, 69 : 491 - 491
12345